A seasoned executive, Terry Rosen has more than 25 years of experience in the biotechnology and pharmaceutical industries. Rosen joined Amgen with the acquisition of Tularik in 2004 and was named Amgen Washington site head in 2006. He transitioned to his leadership role heading Chemistry Research and Discovery in 2007 and became the head of Protein Sciences in 2011. Prior to joining Amgen, Rosen held several executive positions at Tularik including executive vice president, Operations, vice president, Research Operations, and vice president, Medicinal Chemistry. Rosen has also held scientific and management positions at Pfizer and Abbott Laboratories. Rosen serves on the leadership committee of the University of Michigan Undergraduate Research Opportunity Program, the University of California, Berkeley Chemistry Advisory Board and is a member of the Board of Trustees of Lick-Wilmerding High School in San Francisco.
Rosen received his Bachelor of Science in Chemistry from the University of Michigan, Ann Arbor and earned his Doctorate in Organic Chemistry from the University of California, Berkeley. He holds numerous patents and has published extensively in the areas of medicinal and synthetic organic chemistry.